Core Laboratories (NYSE:CLB) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Core Laboratories (NYSE:CLB) released its quarterly earnings data on Wednesday. The oil and gas company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01, Zacks reports. Core Laboratories had a net margin of 6.21% and a return on equity of 12.85%. Core Laboratories updated its Q1 2026 guidance to 0.110-0.150 EPS.

Core Laboratories Price Performance

CLB traded down $0.03 during trading on Wednesday, hitting $19.61. The company’s stock had a trading volume of 332,895 shares, compared to its average volume of 349,873. Core Laboratories has a twelve month low of $9.72 and a twelve month high of $20.36. The firm has a market capitalization of $913.04 million, a price-to-earnings ratio of 29.27, a P/E/G ratio of 17.09 and a beta of 1.09. The company has a current ratio of 2.37, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. The business’s fifty day simple moving average is $17.52 and its 200 day simple moving average is $14.37.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $12.50.

Hedge Funds Weigh In On Core Laboratories

A number of large investors have recently added to or reduced their stakes in the stock. PharVision Advisers LLC purchased a new position in Core Laboratories during the third quarter valued at $218,000. Quantessence Capital LLC acquired a new position in shares of Core Laboratories during the 3rd quarter worth about $192,000. Quarry LP lifted its stake in Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after buying an additional 1,599 shares in the last quarter. Mercer Global Advisors Inc. ADV acquired a new stake in Core Laboratories in the 3rd quarter worth about $132,000. Finally, Lido Advisors LLC purchased a new stake in Core Laboratories during the 3rd quarter worth approximately $553,000. 97.81% of the stock is currently owned by institutional investors and hedge funds.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.